ES2088489T3 - Uso de prostaglandina f3alfa como agente ocular hipotensivo. - Google Patents

Uso de prostaglandina f3alfa como agente ocular hipotensivo.

Info

Publication number
ES2088489T3
ES2088489T3 ES91905633T ES91905633T ES2088489T3 ES 2088489 T3 ES2088489 T3 ES 2088489T3 ES 91905633 T ES91905633 T ES 91905633T ES 91905633 T ES91905633 T ES 91905633T ES 2088489 T3 ES2088489 T3 ES 2088489T3
Authority
ES
Spain
Prior art keywords
f3alfa
prostaglandine
hypotensive
eye agent
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91905633T
Other languages
English (en)
Inventor
David Frederick Woodward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ES2088489T3 publication Critical patent/ES2088489T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eye Examination Apparatus (AREA)
  • Exposure Control For Cameras (AREA)

Abstract

LA INVENCION ESTA RELACIONADA CON UN MEDIO DE REDUCCION O MANTENIMIENTO DE LA PRESION INTRAOCULAR Y, MAS ESPECIFICAMENTE, CON UN METODO Y UNA COMPOSICION PARA REDUCIR O MANTENER LA PRESION INTRAOCULAR QUE IMPLICA LA ADMINISTRACION DE UNA COMPOSICION QUE CONTIENE PROSTAGLANDINA F3O EN UN PORTADOR FARMACEUTICAMENTE ACEPTABLE.
ES91905633T 1990-03-12 1991-02-12 Uso de prostaglandina f3alfa como agente ocular hipotensivo. Expired - Lifetime ES2088489T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/491,546 US5011856A (en) 1990-03-12 1990-03-12 Use of prostaglandin F3 α as an ocular hypotensive agent

Publications (1)

Publication Number Publication Date
ES2088489T3 true ES2088489T3 (es) 1996-08-16

Family

ID=23952683

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91905633T Expired - Lifetime ES2088489T3 (es) 1990-03-12 1991-02-12 Uso de prostaglandina f3alfa como agente ocular hipotensivo.

Country Status (11)

Country Link
US (1) US5011856A (es)
EP (1) EP0527748B1 (es)
JP (1) JPH05504962A (es)
AT (1) ATE138574T1 (es)
CA (1) CA2075951A1 (es)
DE (1) DE69119900T2 (es)
ES (1) ES2088489T3 (es)
FI (1) FI924088A0 (es)
HU (1) HUT61470A (es)
IE (1) IE910794A1 (es)
WO (1) WO1991013620A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270049A (en) * 1990-11-09 1993-12-14 Allergan, Inc. 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives
US5139491A (en) * 1990-12-06 1992-08-18 Allergan, Inc. 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055593A (en) * 1971-02-19 1977-10-25 Alza Corporation Alkyl diethers of prostaglandins
US3940438A (en) * 1971-05-24 1976-02-24 Alza Corporation Crystalline racemic 9α,11α,15(S)-trihydroxy-5-cis,13-trans-prostadienoic acid
US3853854A (en) * 1971-06-24 1974-12-10 Alza Corp Novel 5{40 ,6{40 -dihydro-2h-pyran-4{40 -yl prostaglandin ethers
US4001306A (en) * 1971-12-30 1977-01-04 The Upjohn Company Prostaglandin F.sub.α 15-monoacrylates
US3882245A (en) * 1972-11-01 1975-05-06 Upjohn Co Use of prostaglandins in combating shock
US3941886A (en) * 1973-09-21 1976-03-02 Alza Corporation Pharmaceutical compositions containing crystalline racemic 9α, 11α, 15(S)-trihydroxy-5-cis, 13-trans-prostadienoic acid
US4049678A (en) * 1976-03-29 1977-09-20 The Upjohn Company 9-Deoxy-PGD-type, 1,15-lactones
US4033989A (en) * 1975-09-17 1977-07-05 The Upjohn Company 9-Deoxy-PGF2 Analogs
US4201873A (en) * 1975-09-17 1980-05-06 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD2 analogs
US4016184A (en) * 1975-09-17 1977-04-05 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD1 compounds
US4060540A (en) * 1975-09-18 1977-11-29 American Cyanamid Company Novel 3-triphenylmethoxy-1-alkynes, 3-triphenyl-methoxy-1-trans-alkenyl-dialkyl-alanes, and lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates
US4149007A (en) * 1977-06-23 1979-04-10 Miles Laboratories, Inc. C14 Phenyl-substituted derivatives of prostaglandin analogues
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US4883819A (en) * 1986-07-31 1989-11-28 The Trustees Of Columbia University In The City Of New York Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
US4822819A (en) * 1986-11-07 1989-04-18 Alcon Laboratories, Inc. Use of trimoprostil and derivatives in glaucoma therapy
ZA88963B (en) * 1987-02-27 1989-11-29 Allergan Inc Prostaglandins useful for lowering intraocular pressure
EP0286903B2 (en) * 1987-04-03 2000-03-29 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
SE8703854D0 (sv) * 1987-10-07 1987-10-07 Pharmacia Ab Prostaglandinderivat for behandling av glaukom eller okuler hypertension
ATE164763T1 (de) * 1990-12-10 1998-04-15 Allergan Inc Okulare hypotensive homo-prostaglandinderivate

Also Published As

Publication number Publication date
ATE138574T1 (de) 1996-06-15
CA2075951A1 (en) 1991-09-13
EP0527748A4 (en) 1993-03-10
FI924088A (fi) 1992-09-11
US5011856A (en) 1991-04-30
HUT61470A (en) 1993-01-28
DE69119900D1 (de) 1996-07-04
DE69119900T2 (de) 1997-02-06
EP0527748B1 (en) 1996-05-29
EP0527748A1 (en) 1993-02-24
FI924088A0 (fi) 1992-09-11
IE910794A1 (en) 1991-09-25
JPH05504962A (ja) 1993-07-29
WO1991013620A1 (en) 1991-09-19

Similar Documents

Publication Publication Date Title
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
ES2180530T3 (es) Sulfonamidas de tiofeno utiles como inhibidores de anhidrasa carbonica.
ES2042625T5 (es) Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
ES2036199T3 (es) Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal.
ES2053458T3 (es) Utilizacion de prostaglandinas a, b y c y derivados de las mismas, para el tratamiento de la hipertension ocular y glaucoma.
DK0646008T3 (da) Minimering af gennemblødning i forbindelse med progestin
EP0045617A3 (en) Pharmaceutical composition
HU9203920D0 (en) Pfg 1 alcohols and their application for reducing pressure in eyes
MY106109A (en) 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions
NO972219D0 (no) Immunogenpreparater
AU5355498A (en) 15-fluoro prostaglandins as ocular hypotensives
ES2172485T1 (es) Composiciones oftalmicas en forma de gel acuoso.
DK1187611T3 (da) Oftalmiske histaminholdige sammensætninger og anvendelse deraf
ES2088489T3 (es) Uso de prostaglandina f3alfa como agente ocular hipotensivo.
ES2079872T3 (es) Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina.
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
SE9401087D0 (sv) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
NO923642L (no) Anvendelse av 5-trans-prostaglandin f2alfa som et okulart hypotensivt middel
NO923546L (no) Anvendelse av prostaglandin f3alfa som et okulart hypotensivt midde
HU9301364D0 (en) Homo-prostaglandines applicables for treatment of hypertension in eyes
DK645489D0 (da) Antiglaukompraeparater indeholdende kombinationer af sympatomimetiske midler og beta-1 selektive beta-blokkere
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
ES2089669T3 (es) Utilizacion de los derivados de isoquinolinona en el tratamiento de la hiperlipoproteinemia.
IT1241928B (it) Composizione oftalmica per l'uso nel mantenimento della midriasi oculare
IT1243368B (it) Uso del bendazac e dei suoi sali farmaceuticamente accettabili

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 527748

Country of ref document: ES